CTC-ITB-01 cells display strongly increased HER2 levels in the presence of lapatinib (Figure 4C, right panel), indicating that potential rescue mechanisms may exist that compensate for pharmacological HER2 inhibition in ER+/HER2− breast cancer cells. The gene discussed is ESR1; the disease is breast cancer.